EV/EBITDA
-4.98
+0.05+0.99%
3 min ago
Summary
- As of February 7, 2025, RXRX EV/EBITDA is -4.98, with a rise of +0.05 (+0.99%) during the most recent trading day.
- Over the past year, RXRX EV/EBITDA has increased by +0.79 (+13.69%).
- RXRX EV/EBITDA is now -155.38% below its all-time high of -1.95.
Performance
RXRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RXRX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.0% | -0.9% | -0.8% |
| 1 m1 month | +4.2% | -4.2% | -3.5% |
| 3 m3 months | -4.6% | +4.7% | +3.9% |
| 6 m6 months | -22.4% | +23.4% | +14.0% |
| ytdytd | -8.5% | +8.6% | +7.1% |
| 1 y1 year | +13.7% | -4.5% | -21.4% |
| 5 y5 years | - | - | - |
RXRX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -18.3% | -5.73 | +13.1% | |
| 3 m | 3-month | -3.78 | -31.8% | -5.74 | +13.2% |
| 6 m | 6-month | -3.73 | -33.5% | -5.74 | +13.2% |
| 1 y | 1-year | -3.73 | -33.5% | -10.07 | +50.5% |
| 3 y | 3-year | -1.95 | -155.4% | -11.41 | +56.4% |
| 5 y | 5-year | -1.95 | -155.4% | -65.18 | +92.4% |
| alltime | all time | -1.95 | -155.4% | -65.18 | +92.4% |
Recursion Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -4.98(+8.5%) |
| 2024 | -4.59(-27.0%) |
| Date | Value |
|---|---|
| 2023 | -6.29(+53.4%) |
| 2022 | -4.10(-72.8%) |
| 2021 | -15.09 |
FAQ
- What is Recursion Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Recursion Pharmaceuticals?
- What is RXRX EV/EBITDA year-to-date change?
- What is Recursion Pharmaceuticals EV/EBITDA year-on-year change?
What is Recursion Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of RXRX is -4.98
What is the all time high EV/EBITDA for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high EV/EBITDA is -1.95
What is RXRX EV/EBITDA year-to-date change?
Recursion Pharmaceuticals EV/EBITDA has changed by -0.39 (-8.50%) since the beginning of the year
What is Recursion Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, RXRX EV/EBITDA has changed by +0.79 (+13.69%)